Home Newsfeeds Keybanc Maintains Overweight on Bill.com Holdings, Lowers Price Target to $175

Keybanc Maintains Overweight on Bill.com Holdings, Lowers Price Target to $175

Keybanc analyst Josh Beck maintains Bill.com Holdings (NYSE:BILL) with a Overweight and lowers the price target from $200 to $175.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Keybanc analyst Josh Beck maintains Bill.com Holdings (NYSE:BILL) with a Overweight and lowers the price target from $200 to $175.

Raytheon Technologies Reaffirms FY22 Revenues Of $67.75B-$68.75B Vs $67.74B Est

By Benzinga Newsdesk

September 13, 5:01 PM

The company reaffirms its full year outlook for sales of $67.75 - $68.75 billion, adjusted earnings per share of $4.60 - $4.80 and share repurchase of at least $2.5

RTX

Analyst Ratings

Analyst Ratings For ASML Holding

By Benzinga Insights

January 26, 5:01 PM

4 analysts have shared their evaluations of ASML Holding (NASDAQ:ASML) during the recent three months, expressing a mix…

ASML

CANbridge Announces Encouraging Development In Maralixibat/LIVMARLI In Rare Liver Disease/ Congratulates Partner Mirum On Topline Phase 3 Data In Progressive Familial Intrahepatic Cholestasis

By Benzinga Newsdesk

October 27, 6:18 AM

Congratulates Mirum on Positive Topline Phase 3 Data in progressive familial intrahepatic cholestasis (PFIC) CANbridge holds exclusive Greater China license to maralixibat (CAN108) in liver diseases, China trial

MIRM